MX2023012897A - Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4- dihidropirimidin-2-ona, y mezclas, composiciones y metodos de uso de las mismas. - Google Patents

Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4- dihidropirimidin-2-ona, y mezclas, composiciones y metodos de uso de las mismas.

Info

Publication number
MX2023012897A
MX2023012897A MX2023012897A MX2023012897A MX2023012897A MX 2023012897 A MX2023012897 A MX 2023012897A MX 2023012897 A MX2023012897 A MX 2023012897A MX 2023012897 A MX2023012897 A MX 2023012897A MX 2023012897 A MX2023012897 A MX 2023012897A
Authority
MX
Mexico
Prior art keywords
dihydropyrimidin
tosyl
imino
fluoro
methyl
Prior art date
Application number
MX2023012897A
Other languages
English (en)
Inventor
Judith Aronhime
Stefano Luca Giaffreda
Hanan Sertchook
Enrico Modena
Rotem Sella-Erez
Gal Suez
Cristina Ianni
Chiara Parise
Original Assignee
Adama Makhteshim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adama Makhteshim Ltd filed Critical Adama Makhteshim Ltd
Publication of MX2023012897A publication Critical patent/MX2023012897A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención proporciona formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2(1H)-ona, y usos y procedimientos de preparación de las mismas. La presente invención también proporciona combinaciones, mezclas y composiciones que comprenden las formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2(1H)-ona, y usos y procedimientos de preparación de las mismas.
MX2023012897A 2021-05-04 2022-05-04 Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4- dihidropirimidin-2-ona, y mezclas, composiciones y metodos de uso de las mismas. MX2023012897A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184071P 2021-05-04 2021-05-04
US202163184074P 2021-05-04 2021-05-04
PCT/IB2022/054132 WO2022234487A1 (en) 2021-05-04 2022-05-04 Crystalline forms of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4- dihydropyrimidin-2-one, and mixtures, compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2023012897A true MX2023012897A (es) 2023-12-06

Family

ID=81748425

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023012897A MX2023012897A (es) 2021-05-04 2022-05-04 Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4- dihidropirimidin-2-ona, y mezclas, composiciones y metodos de uso de las mismas.

Country Status (7)

Country Link
EP (1) EP4334291A1 (es)
AU (1) AU2022268726A1 (es)
BR (1) BR112023023105A2 (es)
CA (1) CA3216622A1 (es)
IL (1) IL308155A (es)
MX (1) MX2023012897A (es)
WO (1) WO2022234487A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02530B (me) 2010-04-26 2017-02-20 Adama Makhteshim Ltd N3-supstituisani derivati n1-sulfonil- 5- fluorpirimidinona
JP6609257B2 (ja) 2013-12-31 2019-11-20 アダマ・マクテシム・リミテッド 真菌防除のための相乗的殺真菌性混合物および組成物
SG11201605372QA (en) 2013-12-31 2016-08-30 Adama Makhteshim Ltd 5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1- (arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one and processes for their preparation
MA41272A (fr) 2014-12-23 2017-10-31 Adama Makhteshim Ltd 5-fluoro-4-imino-3-(alkyle/alkyle substitué)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one en tant que traitement des semences
CN106098633B (zh) 2016-06-30 2019-05-21 广州兴森快捷电路科技有限公司 一种封装基板及其制作方法
MA49639A (fr) 2017-07-17 2020-05-27 Adama Makhteshim Ltd Polymorphes de 5-fluoro-4-imino-3-méthyl-1-tosyl-3,4-dihydropyrimidin-2-one
CN108887754A (zh) 2018-09-17 2018-11-27 苏州晶品新材料股份有限公司 一种加热体、雾化装置及电子烟

Also Published As

Publication number Publication date
EP4334291A1 (en) 2024-03-13
WO2022234487A9 (en) 2022-12-15
CA3216622A1 (en) 2022-11-10
IL308155A (en) 2024-01-01
WO2022234487A1 (en) 2022-11-10
AU2022268726A1 (en) 2023-11-23
BR112023023105A2 (pt) 2024-01-30

Similar Documents

Publication Publication Date Title
WO2020243415A3 (en) Tead inhibitors and uses thereof
MX2021006154A (es) Degradadores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
MX2022007576A (es) Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
MX2020007799A (es) Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos.
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
MX2023008031A (es) Inhibidores de la cinasa 2 de control general no desrepresible (gcn2) y usos de los mismos.
WO2020084305A9 (en) Bicyclic peptide ligands and uses thereof
WO2020160193A3 (en) Compounds and uses thereof
WO2021127283A3 (en) Irak degraders and uses thereof
WO2018006074A3 (en) Compounds and methods for modulating rna function
WO2016205531A3 (en) Anti-her2 antibodies and methods of use
MX2019007738A (es) Anticuerpos contra el vih ampliamente neutralizantes y métodos de uso de ellos.
MX2020008125A (es) Composiciones que comprenden berberina.
MY197534A (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
EP4234552A3 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
EP4302827A3 (en) Rapamycin analogs and uses thereof
MX2020013208A (es) Composiciones herbicidas.
WO2020123816A3 (en) Anellosomes and methods of use
MX2020013209A (es) Composiciones herbicidas.
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
MX2022000243A (es) Nuevos compuestos heterociclicos.
MX2023000335A (es) Mezclas fungicidas.